Perspectives of opioid use disorder treatment providers during COVID-19: Adapting to flexibilities and sustaining reforms

OBJECTIVE: The COVID-19 pandemic led to unprecedented temporary federal and state regulatory flexibilities that rapidly transformed medication for opioid use disorder (MOUD) treatment delivery. This study aimed to understand changes in treatment providers' care during COVID-19, provider experie...

Descripción completa

Detalles Bibliográficos
Autores principales: Treitler, Peter C., Bowden, Cadence F., Lloyd, James, Enich, Michael, Nyaku, Amesika N., Crystal, Stephen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8630075/
https://www.ncbi.nlm.nih.gov/pubmed/34098210
http://dx.doi.org/10.1016/j.jsat.2021.108514

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8630075/
https://www.ncbi.nlm.nih.gov/pubmed/34098210
http://dx.doi.org/10.1016/j.jsat.2021.108514

Ejemplares similares